1Pieniazek D, Rayfield M, Hu DJ, et al. Protease sequences from HIV -1 group M subtypes A-H reveals distinct amino acid mutation patterns associated with pro tease resistance in protease inhibitor-naive individuals worldwide[J]. AIDS,2 000, 14: 1489-1495.
2Lech W J, Wang G, Yang Y L, et al. In vivo sequence diversity of th e proteas e of human immunodeficiency virus type 1: presence of protease inhibitor-resista nt variants in untreated subjects[J]. J Virol, 1996,70:2038-2043.
3Deeks S G, Smith M, Holodniy M, et al. HIV-1 protease inhibitors[J ]. J Am Med Assoc,1997,277:145-153.
4Hertogs K, Bloor S, kemp SD, et al. Phenotypic and genotypic analy sis of cl inic HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a sur vey of over 6000 samples[J]. AIDS,2000, 14: 1203-1210.
5Moutouh L, Corbeil J, Richman D D. Recombination leads to the rapi d emergen cd of HIV-1 dually resistant mutants under selective drug pressure[J]. Proc Na tl Acad Sci USA,1996,93:6106-6111.
6Winslow D L, Otto M. J. HIV protease inhibitors[J]. AIDS, 1995,9: S183-S192.
7Wainberg M A, Drosopoulos W C, Salomon H, et al. Enhanced fidelity of 3TC -selected mutant HIV-1reverse transcriptase[J]. Science, 1996,271:1282-1285.
8Boom R, Sol CLA, Salimans MMK, et al. Rapid and simple method for p urification of nucleic acids[J]. J Clin Microbiol,1990,28:495-503.
9Birk M, Sonnerborg A. Variations in HIV-1 pol gene associated with reduced s ensitivity to antiretroviral drugs in treatment-naive patients[J]. AIDS,1998, 12: 2369-2375.
10Conant M, Hardy D. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors[J]. Nature ,1995,374:569-571.
9Condra JH,Holder DJ,Schleif WA,et al.Genetic correlates of in vivo viral resistance to indinavir,a human immunodeficiency virus type 1 protease inhibitor.J Virol,1996,70:8270-8276.
10Kempf DJ,Isaacson JD,King MS,et al.Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients.J Virol,2001,75:7462-7469.
